Complete Revascularization After STEMI: Deciding the Timing With Rising Creatinine
His culprit lesion is already treated — the open question is a significant second lesion, and whether his kidneys can tolerate finishing the job today or need a day or two first.
G.O., a 60-year-old man, was three hours into a return route when the chest pressure started — crushing, radiating to his left arm, bad enough that he pulled off at the next exit and called for help himself rather than trying to push through it, a decision his cardiology team will tell him likely mattered. He arrived with ST elevation across the anterior leads, and primary PCI to a mid-LAD occlusion was successful within the door-to-balloon target, restoring flow with an unremarkable procedure.
The same angiogram that found his culprit lesion also showed an 80% stenosis in an obtuse marginal branch — significant, but not the vessel responsible for today's event, and not causing any hemodynamic instability; he remained Killip class I throughout. That leaves the interventional team with a genuine question the culprit-lesion procedure alone doesn't answer: whether to address the non-culprit lesion now, in the same procedure, or treat it as a separate, staged decision later in the same admission. Complicating the timing question is his renal function. The creatinine drawn on arrival, before any contrast reached him, came back mildly elevated — unremarkable on its own in a man who had been on the road since morning, but it means the primary procedure's contrast load went into kidneys with less reserve than assumed. The rise that load will produce, if it produces one, won't be measurable for another day or two; contrast-associated injury declares itself at 48 to 72 hours, not within the procedure. So the team is deciding about a second contrast exposure without yet being able to see what the first one did. He is otherwise healthy for a man who spends most of his working life behind a wheel — no diabetes, borderline hypertension he's never treated, and a family history of heart disease he'd mentioned to his primary care doctor more than once without ever following up on it.
In the cath lab, mid-procedure
COMPLETE randomized STEMI patients with multivessel disease to culprit-only versus complete revascularization of significant non-culprit lesions, and found a meaningful reduction in cardiovascular death or MI with complete revascularization. His obtuse marginal lesion at 80% is exactly the kind of finding that trial argues for treating, not leaving for a 'we'll see if it becomes symptomatic' approach.
If the non-culprit lesion were only moderately narrowed, or if he were hemodynamically unstable and this were an emergency multivessel intervention, I'd be arguing something different — COMPLETE specifically supports staged treatment of significant, stable non-culprit lesions, not immediate multivessel PCI in every STEMI.
I agree complete revascularization is the better-supported approach here, but COMPLETE's protocol mostly treated the non-culprit lesion as a staged procedure during the index hospitalization, not in the same sitting as the primary PCI. His admission creatinine was already mildly elevated before any contrast reached him, and stacking a second contrast exposure onto the first within the same sitting adds real AKI risk without clear evidence that same-day timing outperforms staging it a day or two later. The point that decides it for me is that we cannot yet see the effect of the contrast we have already given — that reading doesn't exist until 48 to 72 hours out, so proceeding now means committing blind to a dose we can't assess.
I don't disagree that staging is often reasonable — my point is narrower: for a stable, non-culprit lesion in a hemodynamically stable patient, there's no urgency that requires treating it today specifically, and letting his creatinine be followed for 48 to 72 hours before the second procedure lets us see the first exposure's effect before adding to it, without giving up the complete-revascularization benefit.
That timeline makes sense from where I sit managing his admission. I'd plan for staged PCI of the obtuse marginal lesion in two to three days, contingent on his creatinine stabilizing or improving, rather than same-day or open-ended medical management only. In the meantime, his antiplatelet and statin regimen is already appropriately aggressive from the primary PCI, so there's no gap in his coverage while we wait.
Agreed: staged PCI of the obtuse marginal lesion planned for day two or three of admission, contingent on his creatinine stabilizing, with IV hydration in the interim to support renal recovery.
Staged PCI proceeds as planned, completing the trial-supported complete-revascularization approach.
The staged procedure is delayed further, and the non-culprit lesion is managed medically until renal function clearly recovers.
Either way, the non-culprit lesion gets treated on a timeline his kidneys can tolerate, not on the original procedure's clock.